LobbyingTris Pharma lobbying by quarter
Tris Pharma's latest lobbying report covers Q3 2025, at $70K. Its first report covers Q2 2025; the issues it reports most are Health Issues.
Tris Pharma
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q2 2025
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q2 2025 | $200K | 1 |
| Q3 2025 | $70K | 1 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$270K · 2 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES2 reports
- SENATE2 reports
Firms it paid
| Firm | ||
|---|---|---|
| Venn Strategies | $270K | 2 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 25/10/20for Q3 2025 | Venn Strategies | $70K |
| 25/10/20for Q3 2025 | Venn Strategies | $70K |
| 25/07/18for Q2 2025 | Venn Strategies | $200K |
| 25/05/15for Q2 2025 | Venn Strategies | Under $5,000 |